EUVIMEDEUVIMED entdecken
Open Access

Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction

Robert Obermann, Bereket Yemane, Cassie Jarvis, Francisco M Franco, Yevhenii Kyriukha, William Nolan, Beth Gohara, Andrzej M Krezel, Scott A Wildman, James W Janetka iD

ChemMedChem · 16.04.2024 · 19 (8)

DOI: 10.1002/cmdc.202300648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 05.03.2024. Verfasst von Robert Obermann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine, Department of Biochemistry and Molecular Biophysics, 660 S. Euclid Ave., Box 8231, St. Louis, MO, 63110, US…. Hauptthemen laut MEDLINE: Cisplatin, Testicular Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The DNA excision repair protein ERCC1 and the DNA damage sensor protein, XPA are highly overexpressed in patient samples of cisplatin‐resistant solid tumors including lung, bladder, ovarian, and testicular cancer. The repair of cisplatin‐DNA crosslinks is dependent upon nucleotide excision repair (NER) that is modulated by protein‐protein binding interactions of ERCC1, the endonuclease, XPF, and XPA. Thus, inhibition of their function is a potential therapeutic strategy for the selective sensitization of tumors to DNA‐damaging platinum‐based cancer therapy. Here, we report on new small‐molecule antagonists of the ERCC1/XPA protein‐protein interaction (PPI) discovered using a high‐throughput competitive fluorescence polarization binding assay. We discovered a unique structural class of thiopyridine‐3‐carbonitrile PPI antagonists that block a truncated XPA polypeptide from binding to ERCC1. Preliminary hit‐to‐lead studies from compound 1 reveal structure‐activity relationships (SAR) and identify lead compound 27 o with an EC 50 of 4.7 μM. Furthermore, chemical shift perturbation mapping by NMR confirms that 1 binds within the same site as the truncated XPA 67–80 peptide. These novel ERCC1 antagonists are useful chemical biology tools for investigating DNA damage repair pathways and provide a good starting point for medicinal chemistry optimization as therapeutics for sensitizing tumors to DNA damaging agents and overcoming resistance to platinum‐based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinTesticular NeoplasmsHumansMaleDNADNA DamageDNA RepairDNA-Binding ProteinsEndonucleasesPeptidesXeroderma Pigmentosum Group A ProteinFemale

Stichwörter der Autor:innen

DNA damage and repair, cisplatin, chemotherapyERCC1, XPA, XPFNMR structurehigh-throughput screening (HTS)nucleotide excision repair (NER)protein-protein interaction (PPI)small molecule inhibitor

Substanzen

CisplatinDNADNA-Binding ProteinsEndonucleasesERCC1 protein, humanPeptidesXeroderma Pigmentosum Group A ProteinXPA protein, human

Autor:innen und Institutionen

  • Washington University School of Medicine, Department of Biochemistry and Molecular Biophysics, 660 S. Euclid Ave., Box 8231, St. Louis, MO, 63110, USA Tel.

ORCID-Profile: James W Janetka

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Obermann, R., Yemane, B., Jarvis, C., Franco, F. M., Kyriukha, Y., Nolan, W., Gohara, B., Krezel, A. M., Wildman, S. A., & Janetka, J. W. (2024). Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction. ChemMedChem, 19(8). https://doi.org/10.1002/cmdc.202300648

Vancouver

Obermann R, Yemane B, Jarvis C, Franco FM, Kyriukha Y, Nolan W, et al. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction. ChemMedChem. 2024;19(8). doi:10.1002/cmdc.202300648

BibTeX
@article{Obermann2024,
  author = {Obermann, Robert and Yemane, Bereket and Jarvis, Cassie and Franco, Francisco M and Kyriukha, Yevhenii and Nolan, William and Gohara, Beth and Krezel, Andrzej M and Wildman, Scott A and Janetka, James W},
  title = {Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction},
  journal = {ChemMedChem},
  year = {2024},
  volume = {19},
  number = {8},
  doi = {10.1002/cmdc.202300648}
}
Kostenlos starten →